PRICE T ROWE ASSOCIATES INC /MD/ - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 233 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$739
+9.5%
104,315
+8.8%
0.00%
Q2 2023$675
-7.4%
95,842
+9.7%
0.00%
Q1 2023$729
-24.2%
87,328
+4.2%
0.00%
Q4 2022$962
-99.9%
83,824
+2.6%
0.00%
Q3 2022$1,030,000
+27.8%
81,719
+7.3%
0.00%
Q2 2022$806,000
-38.8%
76,146
-6.0%
0.00%
Q1 2022$1,317,000
+8.2%
81,009
-7.8%
0.00%
Q4 2021$1,217,000
-9.8%
87,845
-6.4%
0.00%
Q3 2021$1,349,000
-7.4%
93,857
+1.8%
0.00%
Q2 2021$1,457,000
+49.3%
92,166
-4.0%
0.00%
Q1 2021$976,000
+49.9%
95,990
+9.9%
0.00%
Q4 2020$651,000
+438.0%
87,345
+148.7%
0.00%
Q3 2020$121,000
+128.3%
35,115
+216.1%
0.00%
Q2 2020$53,000
+152.4%
11,110
+7.9%
0.00%
Q1 2020$21,000
-53.3%
10,294
-20.4%
0.00%
Q4 2019$45,000
-69.2%
12,929
-53.7%
0.00%
Q3 2017$146,000
-98.1%
27,923
-96.3%
0.00%
-100.0%
Q4 2015$7,741,000
-38.7%
750,100
-32.2%
0.00%
-33.3%
Q3 2015$12,621,000
+7457.5%
1,107,089
+6399.7%
0.00%
Q3 2014$167,000
-99.0%
17,033
-98.9%
0.00%
-100.0%
Q1 2014$16,748,0001,583,0000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders